{
    "eid": "2-s2.0-85103662149",
    "title": "In schizophrenia, immune-inflammatory pathways are strongly associated with depressive and anxiety symptoms, which are part of a latent trait which comprises neurocognitive impairments and schizophrenia symptoms.",
    "cover-date": "2021-05-15",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Clinical Psychology",
            "@code": "3203",
            "@abbrev": "PSYC"
        },
        {
            "@_fa": "true",
            "$": "Psychiatry and Mental Health",
            "@code": "2738",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "anxiety",
        "biomarkers",
        "depression",
        "inflammation",
        "melancholia",
        "neuro-immune",
        "physiosomatic",
        "schizophrenia"
    ],
    "authors": [
        "Abbas F. Almulla",
        "Khalid F. Al-Rawi",
        "Michael Maes",
        "Hussein Kadhem Al-Hakeim"
    ],
    "citedby-count": 16,
    "ref-count": 96,
    "ref-list": [
        "How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association",
        "High mobility group protein 1 and Dickkopf-Related Protein 1 in Schizophrenia and Treatment-Resistant Schizophrenia: Associations with Interleukin-6, Symptom Domains, and Neurocognitive Impairments",
        "Construction of a Neuro-Immune-Cognitive Pathway-Phenotype Underpinning the Phenome of Deficit Schizophrenia",
        "Chronic fatigue and fibromyalgia symptoms are key components of deficit schizophrenia and are strongly associated with activated immune-inflammatory pathways",
        "Schizophrenia phenomenology revisited: positive and negative symptoms are strongly related reflective manifestations of an underlying single trait indicating overall severity of schizophrenia",
        "Schizophrenia is primed for an increased expression of depression through activation of immuno-inflammatory, oxidative and nitrosative stress, and tryptophan catabolite pathways",
        "Childhood trauma, depression and negative symptoms are independently associated with impaired quality of life in schizophrenia. Results from the national FACE-SZ cohort",
        "The Wnt/planar cell polarity signaling pathway contributes to the integrity of tight junctions in brain endothelial cells",
        "Controlling the false discovery rate: a practical and powerful approach to multiple testing",
        "Depression, traumatic stress and interleukin 6",
        "How should we manage anxiety in patients with schizophrenia?",
        "Anxiety comorbidity in schizophrenia",
        "Depression in schizophrenia: methodological artifact or distinct feature of the illness?",
        "Neuroprogression in schizophrenia: pathways underpinning clinical staging and therapeutic corollaries",
        "Psychotic Depression: Diagnosis, Differential Diagnosis, and Treatment",
        "Automated neuropsychological test battery in depression\u2013preliminary data",
        "Depressive and anxiety symptoms in patients with schizophrenia and schizophreniform disorder",
        "Remission of depression in patients with schizophrenia and comorbid major depressive disorder: results from the FACE-SZ cohort",
        "The psychosis high-risk state: a comprehensive state-of-the-art review",
        "The Positive and Negative Syndrome Scale (PANSS): A three-factor model of psychopathology in marginally housed persons with substance dependence and psychiatric illness",
        "The role of cognitive dysfunction in the symptoms and remission from depression",
        "Panic attacks in schizophrenia",
        "Peripheral chemokine levels in women with recurrent major depression with suicidal ideation",
        "CGI. clinical global impressions. ECDEU assessment manual for psychopharmacology",
        "The assessment of anxiety states by rating",
        "A rating scale for depression",
        "Depression in schizophrenia: associations with cognition, functional capacity, everyday functioning, and self-assessment",
        "Exploring the Wnt signaling pathway in schizophrenia and bipolar disorder",
        "CCL11 or eotaxin-1: An immune marker for ageing and accelerated ageing in neuro-psychiatric disorders",
        "Epidemiology and risk factors of schizophrenia",
        "Changes in Tryptophan Catabolite (TRYCAT) Pathway Patterning Are Associated with Mild Impairments in Declarative Memory in Schizophrenia and Deficits in Semantic and Episodic Memory Coupled with Increased False-Memory Creation in Deficit Schizophrenia",
        "Depressive, anxiety and hypomanic symptoms in schizophrenia may be driven by tryptophan catabolite (TRYCAT) patterning of IgA and IgM responses directed to TRYCATs",
        "Deficit, but not nondeficit, schizophrenia is characterized by mucosa-associated activation of the tryptophan catabolite (TRYCAT) pathway with highly specific increases in IgA responses directed to picolinic, xanthurenic, and quinolinic acid",
        "Physio-somatic symptoms in schizophrenia: association with depression, anxiety, neurocognitive deficits and the tryptophan catabolite pathway",
        "Supervised machine learning to decipher the complex associations between neuro-immune biomarkers and quality of life in schizophrenia",
        "Affective symptoms in schizophrenia are strongly associated with neurocognitive deficits indicating disorders in executive functions, visual memory, attention and social cognition",
        "In Schizophrenia, Depression, Anxiety, and Physiosomatic Symptoms Are Strongly Related to Psychotic Symptoms and Excitation, Impairments in Episodic Memory, and Increased Production of Neurotoxic Tryptophan Catabolites: a Multivariate and Machine Learning Study",
        "The positive and negative syndrome scale (PANSS) for schizophrenia",
        "The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery",
        "The brief negative symptom scale: psychometric properties",
        "Secondary negative symptoms - A review of mechanisms, assessment and treatment",
        "The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system",
        "Wnt/\u03b2-catenin signaling controls development of the blood\u2013brain barrier",
        "Dysfunctional Wnt/\u03b2-catenin signaling contributes to blood\u2013brain barrier breakdown in Alzheimer's disease",
        "Association of neurocognition, anxiety, positive and negative symptoms with coping preference in schizophrenia spectrum disorders",
        "The Compensatory Immune-Regulatory Reflex System (CIRS) in Depression and Bipolar Disorder",
        "Evidence for the existence of major depression with and without anxiety features",
        "Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression",
        "Elevated serum interleukin-6 (IL-6) and IL-6 receptor concentrations in posttraumatic stress disorder following accidental man-made traumatic events",
        "IgM-mediated autoimmune responses directed against anchorage epitopes are greater in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) than in major depression",
        "Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression",
        "Development of a Novel Staging Model for Affective Disorders Using Partial Least Squares Bootstrapping: Effects of Lipid-Associated Antioxidant Defenses and Neuro-Oxidative Stress",
        "Schizophrenia phenomenology comprises a bifactorial general severity and a single-group factor, which are differently associated with neurotoxic immune and immune-regulatory pathways",
        "Lowered Antioxidant Defenses and Increased Oxidative Toxicity Are Hallmarks of Deficit Schizophrenia: A Nomothetic Network Psychiatry Approach",
        "How to construct a bottom-up nomothetic network model and disclose novel nosological classes by integrating risk resilience and adverse outcome pathways with the phenome of schizophrenia",
        "Inflammatory and Oxidative Pathways are New Drug Targets in Multiple Episode Schizophrenia and Leaky Gut, Klebsiella pneumoniae, and C1q Immune Complexes are Additional Drug Targets in First Episode Schizophrenia. Preprints 2020120457 (doi: 10.20944/preprints202012.0457.v1)",
        "Peripheral eotaxin-1 (CCL11) levels and mood disorder diagnosis in a population-based sample of young adults",
        "Dickkopf-related protein-1 inhibition attenuates amyloid-beta pathology associated to Alzheimer's disease",
        "Neurocognitive profile in major depressive disorders: relationship to symptom level and subjective memory complaints",
        "Post-psychotic depression: Paranoia and the damage done",
        "Attention and memory deficits in schizophrenia: the role of symptoms of depression",
        "Chronic fatigue syndrome and fibromyalgia-like symptoms are an integral component of the phenome of schizophrenia: neuro-immune and opioid system correlates",
        "The Endogenous Opioid System in Schizophrenia and Treatment Resistant Schizophrenia: Increased Plasma Endomorphin 2, and \u03ba and \u03bc Opioid Receptors Are Associated with Interleukin-6",
        "Executive functions as a potential neurocognitive endophenotype in anxiety disorders: A systematic review considering DSM-IV and DSM-5 diagnostic criteria classification",
        "The kappa-opiate receptor impacts the pathophysiology and behavior of substance use",
        "Severity of psychotic episodes in predicting concurrent depressive and anxiety features in acute phase schizophrenia",
        "Role of kappa-opioid receptors in the effects of salvinorin A and ketamine on attention in rats",
        "Interleukin-6 induced by social stress promotes a unique transcriptional signature in the monocytes that facilitate anxiety",
        "The Effect of Cognitive Behavioral Interventions on Depression and Anxiety Symptoms in Patients with Schizophrenia Spectrum Disorders: A Systematic Review",
        "Psychosis-related matricide associated with a lesion of the ventromedial prefrontal cortex",
        "Executive functioning in schizophrenia",
        "HIV increases the release of dickkopf-1 protein from human astrocytes by a Cx43 hemichannel-dependent mechanism",
        "Antioxidants as potential therapeutics for neuropsychiatric disorders",
        "The relationship between depression and cognitive deficits",
        "Cognitive functions in bipolar affective disorder and schizophrenia: comparison",
        "Depression and depressive symptoms in first episode psychosis",
        "The role of aberrations in the immune-inflammatory response system (IRS) and the compensatory immune-regulatory reflex system (CIRS) in different phenotypes of schizophrenia: the IRS-CIRS theory of schizophrenia",
        "The role of interleukin-6 signaling in nervous tissue",
        "Social anxiety disorder in schizophrenia: a neglected, yet potentially important comorbidity",
        "Early detection and intervention of psychosis. A review",
        "Role of kappa opioid receptors in symptoms of schizophrenia: What Is the Neurobiology?",
        "Increased Serum Immunoglobulin Responses to Gut Commensal Gram-Negative Bacteria in Unipolar Major Depression and Bipolar Disorder Type 1, Especially When Melancholia Is Present",
        "A detailed examination of cytokine abnormalities in major depressive disorder",
        "A dew schizophrenia model: immune activation is associated with the induction of Different neurotoxic products which together determine memory impairments and schizophrenia symptom dimensions",
        "The macrophage-T-lymphocyte theory of schizophrenia: Additional evidence",
        "Treatment of anxiety disorders by psychiatrists from the American Psychiatric Practice Research Network",
        "Neuropsychologic impairments in bipolar and unipolar mood disorders on the CANTAB neurocognitive battery",
        "Revisiting the role of eotaxin-1/CCL11 in psychiatric disorders",
        "Time course of prefrontal lobe dysfunction in severely depressed in-patients: a longitudinal neuropsychological study",
        "The evolution of depression and suicidality in first episode psychosis",
        "The ageing systemic milieu negatively regulates neurogenesis and cognitive function",
        "Addressing cognitive deficits in schizophrenia: Toward a neurobiologically informed approach",
        "Minocycline Preserves the Integrity and Permeability of BBB by Altering the Activity of DKK1\u2013Wnt Signaling in ICH Model",
        "Evidence for continuing neuropsychological impairments in depression",
        "Rethinking schizophrenia and depression comorbidity as one psychiatric disorder entity: evidence from mouse model"
    ],
    "affiliation": [
        {
            "affiliation-city": "Najaf",
            "@id": "60109789",
            "affilname": "The Islamic University, Najaf",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60109789",
            "affiliation-country": "Iraq"
        },
        {
            "affiliation-city": "Ramadi",
            "@id": "60071163",
            "affilname": "University of Anbar",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60071163",
            "affiliation-country": "Iraq"
        },
        {
            "affiliation-city": "Kufa",
            "@id": "60071160",
            "affilname": "University of Kufa",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60071160",
            "affiliation-country": "Iraq"
        },
        {
            "affiliation-city": "Plovdiv",
            "@id": "60031890",
            "affilname": "Medical University of Plovdiv",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031890",
            "affiliation-country": "Bulgaria"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Geelong",
            "@id": "60018805",
            "affilname": "Deakin University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018805",
            "affiliation-country": "Australia"
        }
    ],
    "funding": []
}